基因型鑑定的全球市場:現狀分析與預測(2021年～2027年)

Genotyping Market: Current Analysis and Forecast (2021-2027)

出版日期: 2022年06月01日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 233 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球基因型鑑定的市場規模在預測期間(2021年～2027年)中預計將以約20％的年複合成長率成長。

罕見病基因分型通過幫助確定未確診疾病的原因並防止他們多年去醫院或進行不必要的檢查，從而推動市場增長。此外，癌症等疾病的日益流行也增加了對基因分型診斷的需求。

本報告提供全球基因型鑑定市場的相關調查，提供市場洞察，市場趨勢，競爭模式，企業概要等全面性資訊。

Global Genotyping Market is anticipated to grow with an elevated CAGR of around 20% over the forecast period (2021-2027). Genotyping is the process of determining the DNA sequence, called a genotype, at specific positions within the genome of an individual. Sequence variations can be used as markers in linkage and association studies to determine genes relevant to specific traits or diseases.

The genotyping of rare disease help doctors pinpoint the cause of undiagnosed disorders, helping families avoid years of hospital visits and unnecessary tests. These factors are anticipated to boost the market. Furthermore, the increasing prevalence of diseases like cancer along with the surging incidences of rare diseases rises the demand for genotyping diagnostics. According to the ministry of health and welfare of the family, it is estimated that globally around 6000 to 8000 rare diseases exist with new rare diseases being reported in the medical literature regularly. The increasing interest of the global players and the institutions along with the continuous growth of the biotechnology industry also drives the market for genotyping. For instance, As per Invest India, In 2020, the Biotech industry reached a market size of $ 70.2 Bn, rising 12.3% from the previous year. The bioeconomy has observed almost a 95% increase in valuation over the period of five years.

llumina Inc., Thermo Fisher Scientific Inc., Qiagen Inc., F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Danaher Corporation, Agilent Technologies, Eurofins Scientific Inc., GE Healthcare Inc., and Bio-Rad Laboratories Inc, are some of the prominent players operating in the Genotyping market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new varieties of Genotyping devices.

Insights Presented in the Report

"Amongst Product/Services, Reagents & Kits segment holds the major share"

Based on product/services, the market is fragmented into Reagents & Kits, Genotyping Services, Instruments, and Bioinformatics. The Reagents & Kits segment accounted for a significant market share in 2020 this is mainly due to the increasing investments in R&D and increasing demand for genetic testing drives the market for genotyping industry. However, the bioinformatic segment is expected to witness lucrative growth in the genotyping market owing to the increasing demand for software and the better databases require to store the genetic information. Furthermore, the integration of the devices with the internet and the public network also drives the segmental growth during the forecast period.

"Amongst Technology, sequencing segment is expected to hold the major share"

Based on technology, the market is segmented into PCR, sequencing, electrophoresis, microarray, and others. The PCR segment grabbed a significant market share in 2020. The continuously rising number of incidences of genetic disorders and the deaths raise the growth of the PCR. During the forecast, the sequencing segment is expected to have a considerable market share. This is mainly due to the technological advancement in sequencing technology and frequent product launches by the companies. For instance, in January 2021, Stanford Launched Clinical Whole-Genome Sequencing for Inherited Cardiovascular Testing.

"Amongst end-users, diagnostic & research segment expected to hold the major share"

Based on end-users, the market is fragmented into pharmaceutical & biotechnology companies, hospitals and clinics, academic & government institutes, diagnostic & research institutions, and others. The pharmaceutical & biotechnology companies held a significant market share in 2020. Genomics is enabling pharmaceutical companies to take a more personalized approach to drug development and is expected to result in safer and more effective drugs. However, the diagnostic & research institution segment is predicted to have a significant share in genotyping market in the future. This is mainly due to increasing investment in R&D worldwide along with an increasing number of cases of genetic disorders. For instance, as per UNESCO, Global spending on R&D has reached a record high of almost US$ 1.7 trillion. About 10 countries account for 80% of spending.

"North America represents one of the largest markets of Genotyping market"

For a better understanding of the market dynamics of the Genotyping market, a detailed analysis was conducted for different regions across the globe including North America (U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. In 2020, North America dominated the Genotyping industry. This can be mainly due to the presence of well-established market players and frequent product launches along with the presence of government-funded organizations in the region. For instance, The National Human Genome Research Institute (NHGRI) is a part of the National Institutes of Health (NIH) are government organization supported and funded by the U.S government that has a record of the human genome and the genetic disorder.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts

The report presents a quick review of overall industry performance at one glance

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry

The study comprehensively covers the market across different segments

Deep dive regional level analysis of the industry

Customization Options:

The global genotyping market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Limitation
1.3. Stakeholders
1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Genotyping Market
2.2. Research Methodology of the Genotyping Market
2.3. Forecasting Method
2.4. Respondent Profile
2.5. Main Objective of the Genotyping Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL GENOTYPING MARKET COVID-19 IMPACT

6 GLOBAL GENOTYPING MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT/SERVICE TYPE

7.1. Reagents & Kits
7.2. Genotyping Services
7.3. Instruments
7.4. Bioinformatics

8 MARKET INSIGHTS BY TECHNOLOGY

8.1. PCR
8.2. Sequencing
8.3. Electrophoresis
8.4. Microarray
8.5. Others

9 MARKET INSIGHTS BY END-USERS

9.1. Pharmaceutical & Biotechnology companies
9.2. Hospitals and clinics
9.3. Academic & government institutes
9.4. Diagnostic & research institutions
9.5. Others

10 MARKET INSIGHTS BY REGION

10.1. North America Genotyping Market
- 10.1.1. United States
- 10.1.2. Canada
- 10.1.3. Rest of North America
10.2. Europe Genotyping Market
- 10.2.1. Germany
- 10.2.2. France
- 10.2.3. U.K.
- 10.2.4. Italy
- 10.2.5. Spain
- 10.2.6. Rest of Europe
10.3. Asia Pacific Genotyping Market
- 10.3.1. China
- 10.3.2. Japan
- 10.3.3. India
- 10.3.4. Australia
- 10.3.5. Rest of Asia Pacific
10.4. Rest of World Genotyping Market